Carmell Therapeutics Corporation (CTCX) — Tangible Net Worth Ratio
Carmell Therapeutics Corporation (CTCX) has a Tangible Net Worth Ratio of 99.9% as of December 2023. This metric is calculated by deducting intangible assets ($24.19K) from net assets ($24.75 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CTCX total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Carmell Therapeutics Corporation Tangible Net Worth Ratio (2023–2023)
This chart shows how Carmell Therapeutics Corporation's Tangible Net Worth Ratio has changed across 1 annual periods from 2023 to 2023. As of December 2023, the ratio stands at 99.9%, reflecting net assets of $24.75 Million with intangible assets of $24.19K USD. Also explore net asset growth rate of Carmell Therapeutics Corporation to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Carmell Therapeutics Corporation (2023–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Carmell Therapeutics Corporation from 2023 to 2023, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Carmell Therapeutics Corporation stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 99.9% | $24.75 Million | $24.19K | $63.95 Million | — |